Piritrexim isethionate
Product Specifications
CAS Number
79483-69-5
Target
Others, DHFR
Related Pathways
Cell Cycle/Checkpoint, DNA Damage/DNA Repair, Others, Metabolism
Bioactivity
Piritrexim isethionate is a lipid-soluble inhibitor of dihydrofolate reductase (DHFR) that appears to be an active agent in patients with metastatic urothelial cancer when administered as a 5-day, low-dose oral schedule.
Smiles
OCCS(O)(=O)=O.COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1
Molecular Formula
C19H25N5O6S
Molecular Weight
451.49
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1405019-01 0.02 mg (E-Coli)
Recombinant Human Serine/threonine-protein kinase PAK 2 (PAK2)
Sign In for Pricing
View Details MBS1405019-02 0.02 mg (Yeast)
Recombinant Human Serine/threonine-protein kinase PAK 2 (PAK2)
Sign In for Pricing
View Details MBS1405019-03 0.1 mg (E-Coli)
Recombinant Human Serine/threonine-protein kinase PAK 2 (PAK2)
Sign In for Pricing
View Details MBS1405019-04 0.1 mg (Yeast)
Recombinant Human Serine/threonine-protein kinase PAK 2 (PAK2)
Sign In for Pricing
View Details MBS1405019-05 0.02 mg (Baculovirus)
Recombinant Human Serine/threonine-protein kinase PAK 2 (PAK2)
Sign In for Pricing
View Details MBS1405019-06 0.02 mg (Mammalian-Cell)
Recombinant Human Serine/threonine-protein kinase PAK 2 (PAK2)
Sign In for Pricing
View Details